Real-World Study of Once-Daily, Extended-Release Tacrolimus Versus Twice-Daily, Immediate-Release Tacrolimus in Kidney Transplantation: Clinical Outcomes and Healthcare Resource Utilization Author Name Bing Ho et al Category Computer science, information & general works Type Journal Tags Calcineurin inhibitor,Glomerular filtration rate (GFR),Graft survival,Immunosuppressant,Kidney (allograft) function/dysfunction,Patient characteristics,Tacrolimus,Urology Login to Access Content
